Cresco Labs Inc.
CL
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.82% | -6.69% | -5.33% | -5.28% | -6.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.82% | -6.69% | -5.33% | -5.28% | -6.55% |
| Cost of Revenue | -6.73% | -9.52% | -11.90% | -15.92% | -16.28% |
| Gross Profit | -8.93% | -3.55% | 2.40% | 8.18% | 5.98% |
| SG&A Expenses | -1.51% | -5.52% | -13.36% | -22.15% | -23.71% |
| Depreciation & Amortization | -21.85% | -16.28% | -11.28% | 27.78% | 39.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.49% | -8.33% | -12.42% | -17.10% | -17.78% |
| Operating Income | -20.69% | 5.11% | 68.11% | 241.92% | 278.68% |
| Income Before Tax | 112.33% | 77.09% | 92.77% | 99.73% | 27.78% |
| Income Tax Expenses | 72.72% | 35.27% | 51.36% | 13.22% | -58.43% |
| Earnings from Continuing Operations | 77.52% | 52.19% | 66.37% | 84.66% | 36.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.71% | -1,659.05% | -422.15% | -143.99% | -149.69% |
| Net Income | 73.51% | 45.90% | 57.59% | 80.14% | 26.21% |
| EBIT | -20.69% | 5.11% | 68.11% | 241.92% | 278.68% |
| EBITDA | -19.72% | -2.25% | 32.48% | 101.82% | 111.07% |
| EPS Basic | 74.34% | 48.20% | 59.83% | 81.89% | 33.93% |
| Normalized Basic EPS | 172.80% | -237.02% | -486.86% | -197.88% | -3,309.09% |
| EPS Diluted | 74.34% | 48.20% | 59.83% | 81.89% | 33.93% |
| Normalized Diluted EPS | 172.80% | -237.02% | -486.86% | -197.88% | -3,309.09% |
| Average Basic Shares Outstanding | 2.69% | 4.40% | 6.71% | 9.13% | 11.57% |
| Average Diluted Shares Outstanding | 2.69% | 4.40% | 6.71% | 9.13% | 11.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |